NeoMatriX® Wound Matrix
New Skin in The Game
About NeoMatriX®
NeoMatriX® Wound Matrix is fabricated from the dermal extracellular matrix of axolotl. NeoMatriX® is provided as sheets of various sizes for placement on wound beds to help manage the wound environment.
Indications for Use
NeoMatriX® Wound Matrix is intended for the management of wounds including:
This device is terminally sterilized using gamma irradiation and is intended for one-time use.
• Partial and full-thickness wounds
• Pressure ulcers
• Venous ulcers
• Diabetic ulcers
• Chronic vascular ulcers
• Tunneled/undermined wounds
• Surgical wounds (donor sites/grafts
post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence)
• Trauma wounds (abrasions, lacerations, partial thickness burns, skin tears)
• Draining wounds
Biocompatibility & safety Testing
Available in the United States late 2022
NeoMatriX® has been rigorously tested in accordance with recognized biocompatibility standards
• Cytotoxicity
• Sensitization
• Irritation/intracutaneous reactivity
• Acute systemic toxicity
• Pyrogenicity
• Subacute and sub-chronic toxicity
• Genotoxicity
• Endotoxin testing was conducted according to AAMI ST72
• Sterilization validation using gamma radiation to a sterility assurance alevel of 10-6
• Viral inactivation testing was also performed
• Pre-clinical testing showing non-inferiority in a porcine wound healing amodel
• Clinical testing indicating that NeoMatriX Wound Matrix does not raise aimmunogenicity concerns when used in humans
Copyright 2021. All Right Reserved / MKT-001 Rev 0 / Designed By SPG
